News
FDA approves biosimilar rituximab for NHL
The U.S.
News
EC approves product for hemophilia A
The European Commission (EC) has approved damoctocog alfa pegol (Jivi®), a recombinant human factor VIII therapy. Damoctocog alfa pegol (formerly...
News
EC approves mogamulizumab for MF, SS
The European Commission (EC) has granted marketing authorization for mogamulizumab (Poteligeo), a humanized monoclonal antibody directed against...
News
Canada expands approval for antihemophilic factor
Health Canada has extended the approved indication for Adynovate, a recombinant pegylated factor VIII (FVIII) product, in patients with hemophilia...
News
Pegfilgrastim biosimilar approved by EC
The European Commission (EC) has granted marketing authorization for Sandoz’s pegfilgrastim product Ziextenzo®, a biosimilar of Amgen’s Neulasta...
News
Older people with CHIP are safe donor source for HSCT
New research suggests older individuals with clonal hematopoiesis of indeterminate potential (CHIP) are a safe donor source for allogeneic...
News
EC approves pegfilgrastim biosimilar
The European Commission (EC) has approved Mundipharma’s pegfilgrastim product Pelmeg, a biosimilar of Amgen’s Neulasta. Pelmeg is approved for...
News
FDA grants priority review to quizartinib
The U.S.
News
ASH expands late-breaking abstract session
An additional presentation has been added to the late-breaking abstract session of the 2018 ASH Annual Meeting. The session was expanded from six...
News
Americans concerned about cost of cancer care
A recent survey suggests Americans are nearly as worried about the cost of a cancer diagnosis as they are about dying from cancer. The cost of...
News
CHMP backs blinatumomab for MRD
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding marketing authorization for...
News
Eltrombopag approved as first-line SAA therapy
The U.S.
News
Quick FDA approval for brentuximab vedotin in PTCL
The U.S.
News
FDA approves generic drugs for APL
The U.S.
News
FDA approves generic decitabine for MDS
The U.S. Food and Drug Administration has approved Lupin’s decitabine product, a generic version of Otsuka Pharmaceutical Co.